“Superlative transactional IP work, especially in cutting-edge technologies, such as blockchain, medical technology and machine learning“ IAM MAGAZINE 2019

  • He
  • En
  • Home
  • The Firm
  • Practice Areas
  • Attorneys
  • News & Publications
  • Contact
  • He
  • En

Yuval Horn and Keren Kanir of Horn & Co. represented Anima Biotech in an exclusive collaboration agreement with Eli Lilly, with a total deal value exceeding $1 billion.